BioSpace News Archive

Business

Promore Pharma Release: Interim Report January - September 2017

Overall, the company’s main activities during the third quarter have been focused on continued planning of our clinical commitments.

November 21, 2017

·

6 min read

BioMidwest

Life Spine Announces Alpha Launch of SIMPACT TRI-FIN Sacroiliac Joint Fixation Screws

The SIMPACT TRI-FIN system was designed with an anti-rotational sleeve to inhibit component back out, and a screw thread design which affords the surgeon the ability to compress and stabilize the SI joint.

November 21, 2017

·

2 min read

Policy

Illumina Wins Infringement Suit Against Premaitha Health and Ariosa Diagnostics

The Court found that Premaitha’s IONA test infringed EP 1 981 995, EP 2 385 143, EP 2 183 693 and EP 2 514 842, which are generally directed to the use of sequencing in non-invasive prenatal testing (NIPT).

November 21, 2017

·

1 min read

Biotech Bay

Bio-Rad to Webcast Investor Day 2017

The presentations and webcast will begin at 9 AM (ET).

November 21, 2017

·

1 min read

Genetown

Thermo Fisher Scientific Recommends Shareholders Reject Mini-Tender Offer by TRC Capital Corporation

The offer is for approximately 0.249% of Thermo Fisher’s outstanding shares of common stock as of the offer date.

November 21, 2017

·

3 min read

Business

Medicure Reports Financial Results for Quarter Ended September 30, 2017

Recorded net revenue from the sale of AGGRASTAT of $7M during the quarter ended September 30, 2017 compared to $8.2M for the quarter ended September 30, 2016.

November 21, 2017

·

28 min read

Pharm Country

Fujifilm Launches New Pediatric Solutions Portfolio at RSNA 2017

Fujifilm will unveil the comprehensive pediatrics portfolio in a dedicated display at booth #4111 at McCormick Place in Chicago during the 103rd scientific assembly and annual meeting of the RSNA.

November 21, 2017

·

6 min read

Pharm Country

Janssen Announces U.S. FDA Approval of First and Only Complete, Single-Pill, Two-Drug Regimen, JULUCA (Dolutegravir and Rilpivirine), for the Treatment of HIV-1 Infection

JULUCA is a once-daily, antiretroviral combination of dolutegravir, an INSTI marketed by ViiV Healthcare as TIVICAY, and rilpivirine, a non-NNRTI marketed by Janssen as EDURANT.

November 21, 2017

·

17 min read

Pharm Country

Fujifilm Exhibits Comprehensive Medical Informatics and Enterprise Imaging Portfolio at RSNA 2017

As the centerpiece of Fujifilm’s comprehensive Enterprise Imaging portfolio, Fujifilm TeraMedica’s patented Synapse VNA leads the vendor-neutral archive market by integrating more specialties, more devices, and more data than any other VNA.

November 21, 2017

·

4 min read

BioForest

FUJIFILM SonoSite Presents Point-of-Care Ultrasound Portfolio At RSNA 2017

“Fujifilm SonoSite is here to help our customers increase workflow efficiencies to deliver better care and improved patient outcomes with our leading point-of-care ultrasound technologies.”

November 21, 2017

·

4 min read